A humoral immune response after competition of COVID-19 vaccine series is detected in most patients with inflammatory bowel disease, including those on immunosuppressants, according to a presentation at the ACG Scientific Annual Meeting.

“The vast majority (95%) of IBD patients including those on immunosuppressive medications mounted an initial antibody response after completing the two-part mRNA SARS-CoV-2 vaccine series,” Kimberly N. Weaver, MD, assistant professor in the division of gastroenterology and hepatology at the University of North Carolina School of Medicine in Chapel

Full Article: https://www.healio.com/news/gastroenterology/20211025/substantial-humoral-immune-response-observed-in-ibd-patients-after-covid19-vaccine-series